Development of prophylactic and therapeutic vaccines using the ISCOMATRIX adjuvant-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of prophylactic and therapeutic vaccines using the ISCOMATRIX adjuvant

Published:2009-04-21 Issue:5 Volume:87 Page:371-376
ISSN:0818-9641
Container-title:Immunology & Cell Biology
language:en
Short-container-title:Immunol Cell Biol

Author:

Maraskovsky Eugene¹,Schnurr Max²,Wilson Nick S³,Robson Neil C⁴,Boyle Jeff¹,Drane Debbie⁵

Affiliation:

1. CSL Limited, Bio21 Institute Parkville Victoria Australia

2. Department of Internal Medicine, University of Munich Munich Germany

3. Department of Molecular Oncology, Genentech Inc. South San Francisco CA USA

4. Ludwig Institute for Cancer Research, Melbourne Centre for Clinical Sciences, Austin Health Heidelberg Victoria Australia

5. Research and Development Department, CSL Limited Parkville Victoria Australia

Publisher

Wiley

Subject

Cell Biology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1038/icb.2009.21

Reference39 articles.

1. Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses

2. A Novel Generation of Viral Vaccines Based on the ISCOM Matrix

3. The ISCOMATRIX™ adjuvant

4. ISCOMATRIX™ adjuvant for prophylactic and therapeutic vaccines

5. Recent advances in the discovery and delivery of vaccine adjuvants

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Saponin nanoparticle adjuvants incorporating Toll-like receptor agonists drive distinct immune signatures and potent vaccine responses;Science Advances;2024-08-09

2. Enhancement of the immunogenicity of a Mycobacterium tuberculosis fusion protein using ISCOMATRIX and PLUSCOM nano-adjuvants as prophylactic vaccine after nasal administration in mice;IRAN J BASIC MED SCI;2024

3. Saponin-based adjuvants enhance antigen cross-presentation in human CD11c⁺CD1c⁺CD5⁻CD163⁺conventional type 2 dendritic cells;Journal for ImmunoTherapy of Cancer;2023-08

4. Saponin Nanoparticle Adjuvants Incorporating Toll-Like Receptor Agonists Drive Distinct Immune Signatures and Potent Vaccine Responses;2023-07-31

5. Development of low-cost cage-like particles to formulate veterinary vaccines;Veterinary Immunology and Immunopathology;2022-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3